<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">vaccine </span>
   <span class="font30">hepatitis </span>
   <span class="font21">testing </span>
   <span class="font19">reduction </span>
   <span class="font18">PWID </span>
   <span class="font18">incidence </span>
   <span class="font17">countries </span>
   <span class="font17">general </span>
   <span class="font16">treatment </span>
   <span class="font16">cost </span>
   <span class="font15">vaccination </span>
   <span class="font15">population </span>
   <span class="font15">prevalence </span>
   <span class="font15">Appendix </span>
   <span class="font14">elimination </span>
   <span class="font14">file </span>
   <span class="font14">model </span>
   <span class="font14">optimal </span>
   <span class="font14">strategy </span>
   <span class="font14">people </span>
   <span class="font14">{border-style </span>
   <span class="font13">costs </span>
   <span class="font13">high </span>
   <span class="font13">settings </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">impact </span>
   <span class="font13">(Additional </span>
   <span class="font13">[]. </span>
   <span class="font13">target </span>
   <span class="font13">coverage </span>
   <span class="font13">health </span>
   <span class="font13">transmission </span>
   <span class="font12">US$ </span>
   <span class="font12">[], </span>
   <span class="font12">modelled </span>
   <span class="font12">sensitivity </span>
   <span class="font12">additional </span>
   <span class="font12">community </span>
   <span class="font12">programmes </span>
   <span class="font12">strategies </span>
   <span class="font12">test </span>
   <span class="font12">assumed </span>
   <span class="font12">course </span>
   <span class="font12">duration </span>
   <span class="font12">prevention </span>
   <span class="font12">required </span>
   <span class="font12">uncertainty </span>
   <span class="font12">E—Table </span>
   <span class="font12">Health </span>
   <span class="font12">US$. </span>
   <span class="font12">achieve </span>
   <span class="font12">efficacy </span>
   <span class="font12">epidemic </span>
   <span class="font12">estimated </span>
   <span class="font12">number </span>
   <span class="font12">scenarios </span>
   <span class="font12">data </span>
   <span class="font12">efficacious </span>
   <span class="font12">inject </span>
   <span class="font12">interventions </span>
   <span class="font12">price </span>
   <span class="font12">reduce </span>
   <span class="font12">reduced </span>
   <span class="font12">tested </span>
   <span class="font12">total </span>
   <span class="font12">used </span>
   <span class="font11">analysis </span>
   <span class="font11">available </span>
   <span class="font11">average </span>
   <span class="font11">based </span>
   <span class="font11">concentrated </span>
   <span class="font11">epidemics </span>
   <span class="font11">infection </span>
   <span class="font11">mixed </span>
   <span class="font11">study </span>
   <span class="font11">-year </span>
   <span class="font11">Fig. </span>
   <span class="font11">S). </span>
   <span class="font11">World </span>
   <span class="font11">available, </span>
   <span class="font11">countries, </span>
   <span class="font11">covered </span>
   <span class="font11">generalised </span>
   <span class="font11">global </span>
   <span class="font11">programme </span>
   <span class="font11">px; </span>
   <span class="font11">vaccines </span>
   <span class="font11">{font-family </span>
   <span class="font11">HCV </span>
   <span class="font11">However, </span>
   <span class="font11">Research </span>
   <span class="font11">antibody </span>
   <span class="font11">billion </span>
   <span class="font11">considered </span>
   <span class="font11">countries. </span>
   <span class="font11">font-size </span>
   <span class="font11">harm </span>
   <span class="font11">injecting </span>
   <span class="font11">non-dominated </span>
   <span class="font11">provided </span>
   <span class="font11">require </span>
   <span class="font11">treat </span>
   <span class="font11">viral </span>
   <span class="font11">virus </span>
   <span class="font11">(%) </span>
   <span class="font11">(i.e. </span>
   <span class="font11">Additional </span>
   <span class="font11">PWID. </span>
   <span class="font11">analysis. </span>
   <span class="font11">assumptions </span>
   <span class="font11">care </span>
   <span class="font11">case </span>
   <span class="font11">community, </span>
   <span class="font11">country </span>
   <span class="font11">development </span>
   <span class="font11">diagnosed </span>
   <span class="font11">different </span>
   <span class="font11">double; </span>
   <span class="font11">drugs </span>
   <span class="font11">elimination. </span>
   <span class="font11">following </span>
   <span class="font11">genotype </span>
   <span class="font11">healthcare </span>
   <span class="font11">included </span>
   <span class="font11">infected </span>
   <span class="font11">period </span>
   <span class="font11">phase </span>
   <span class="font11">potential </span>
   <span class="font11">protection </span>
   <span class="font11">reducing </span>
   <span class="font11">screening </span>
   <span class="font11">settings, </span>
   <span class="font11">susceptible </span>
   <span class="font11">tests </span>
   <span class="font11">vaccinated </span>
   <span class="font11">vaccine. </span>
   <span class="font11">(IQR </span>
   <span class="font11">.collab: </span>
   <span class="font11">Hepatitis </span>
   <span class="font11">Table </span>
   <span class="font11">achievable </span>
   <span class="font11">achieved </span>
   <span class="font11">approximately </span>
   <span class="font11">article </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">bounds </span>
   <span class="font11">calibrated </span>
   <span class="font11">classified </span>
   <span class="font11">country, </span>
   <span class="font11">currently </span>
   <span class="font11">delivered </span>
   <span class="font11">determined </span>
   <span class="font11">drug </span>
   <span class="font11">economic </span>
   <span class="font11">estimates, </span>
   <span class="font11">follow-up </span>
   <span class="font11">frequency </span>
   <span class="font11">human </span>
   <span class="font11">include </span>
   <span class="font11">individuals </span>
   <span class="font11">likely </span>
   <span class="font11">majority </span>
   <span class="font11">meaning </span>
   <span class="font11">median </span>
   <span class="font11">modelling </span>
   <span class="font11">monthly </span>
   <span class="font11">mortality </span>
   <span class="font11">parameters </span>
   <span class="font11">programmes, </span>
   <span class="font11">programmes. </span>
   <span class="font11">public </span>
   <span class="font11">reached </span>
   <span class="font11">reaching </span>
   <span class="font11">relative </span>
   <span class="font11">results </span>
   <span class="font11">review </span>
   <span class="font11">risk </span>
   <span class="font11">role </span>
   <span class="font11">scenario </span>
   <span class="font11">size </span>
   <span class="font11">solid; </span>
   <span class="font11">specific </span>
   <span class="font11">systematic </span>
   <span class="font11">time </span>
   <span class="font11">use </span>
   <span class="font11">using </span>
   <span class="font11">vaccine, </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(US$.–.) </span>
   <span class="font10">(e.g. </span>
   <span class="font10">Accessed </span>
   <span class="font10">Assumes </span>
   <span class="font10">DAA </span>
   <span class="font10">Medical </span>
   <span class="font10">Model </span>
   <span class="font10">PWID, </span>
   <span class="font10">RNA </span>
   <span class="font10">University </span>
   <span class="font10">University, </span>
   <span class="font10">according </span>
   <span class="font10">achieving </span>
   <span class="font10">adequately </span>
   <span class="font10">adolescents </span>
   <span class="font10">age </span>
   <span class="font10">age-based </span>
   <span class="font10">aggregate </span>
   <span class="font10">alternate </span>
   <span class="font10">available. </span>
   <span class="font10">benefits </span>
   <span class="font10">bold </span>
   <span class="font10">clearance </span>
   <span class="font10">combinations </span>
   <span class="font10">community. </span>
   <span class="font10">courier; </span>
   <span class="font10">cumulative </span>
   <span class="font10">deliver </span>
   <span class="font10">derive </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">epidemiology </span>
   <span class="font10">feasibility </span>
   <span class="font10">fraction </span>
   <span class="font10">from: </span>
   <span class="font10">future </span>
   <span class="font10">implement </span>
   <span class="font10">implementation </span>
   <span class="font10">increase </span>
   <span class="font10">levels </span>
   <span class="font10">major </span>
   <span class="font10">manuscript. </span>
   <span class="font10">models </span>
   <span class="font10">non-vaccine </span>
   <span class="font10">order </span>
   <span class="font10">parameter </span>
   <span class="font10">point </span>
   <span class="font10">populations </span>
   <span class="font10">positivity </span>
   <span class="font10">protection, </span>
   <span class="font10">pt;} </span>
   <span class="font10">rate </span>
   <span class="font10">research </span>
   <span class="font10">scale-up </span>
   <span class="font10">significant </span>
   <span class="font10">support </span>
   <span class="font10">syringe </span>
   <span class="font10">testing, </span>
   <span class="font10">theoretical </span>
   <span class="font10">therapy </span>
   <span class="font10">treated </span>
   <span class="font10">treatment, </span>
   <span class="font10">treatment. </span>
   <span class="font10">way </span>
   <span class="font10"> days </span>
   <span class="font10"> years </span>
  </p>
 </body>
</html>
